Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Jones

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
JAMA Network Open|April 1, 2024
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar DegenerationAdam M Staffaroni, Annie L Clark, Jack C Taylor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Ani Eloyan, Maryanne Thangarajah, Na An, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2023
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohortAngelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, et al.
JAMA Neurology|April 15, 2024
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer DiseaseNaomi Kouri, Isabelle Frankenhauser, Zhongwei Peng, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2023
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Hanna Cho, Nidhi S Mundada, Liana G Apostolova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.
Brain Communications|June 8, 2026
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's diseaseMarlene Lin, Konstantinos Chiotis, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 15, 2025
Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's diseaseWepnyu Yembe Njamnshi, Konstantinos Chiotis, Elena Tsoy, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's diseaseKonstantinos Chiotis, Ganna Blazhenets, David N Soleimani-Meigooni, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
JAMA Network Open|April 1, 2024
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar DegenerationAdam M Staffaroni, Annie L Clark, Jack C Taylor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Ani Eloyan, Maryanne Thangarajah, Na An, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2023
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohortAngelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, et al.
JAMA Neurology|April 15, 2024
Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer DiseaseNaomi Kouri, Isabelle Frankenhauser, Zhongwei Peng, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2023
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Hanna Cho, Nidhi S Mundada, Liana G Apostolova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.
Brain Communications|June 8, 2026
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's diseaseMarlene Lin, Konstantinos Chiotis, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 15, 2025
Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's diseaseWepnyu Yembe Njamnshi, Konstantinos Chiotis, Elena Tsoy, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's diseaseKonstantinos Chiotis, Ganna Blazhenets, David N Soleimani-Meigooni, et al.
Pageof 38